42 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Recommendations for Preventing ... known to have HIV ... Preventing First ... HumanPapillomavirus #IDSA #Prevention ... Treatment #management #opportunistic
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Preventing Bacterial ... • In rare cases ... Bacterial #IDSA #Prevention ... Treatment #management #opportunistic
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Infections in HIV-AIDS ... Preventing 1st ... to 5 mg/kg/day IV ... Treatment #management #opportunistic
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Recommendations for Preventing ... Trypanosomiasis) in HIV-AIDS ... Preventing Clinical ... parasitemia and preventing ... Treatment #management #opportunistic
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
CNS Opportunistic ... : • Most CNS opportunistic ... • CNS opportunistic ... present in 15% of cases ... Demyelinating disease caused
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
symptoms • >50,000 HIV ... elevation • Nausea ... Presentations: • Opportunistic ... 14%), in which case ... opportunistic infections
Acute Otitis Externa (Swimmer’s Ear): Pathogenesis and clinical findings
Pathogens = Pseudomonas aeruginosa (most common opportunistic), Staphylococcus,
aeruginosa (most common opportunistic ... Immunocompromized (HIV ... of cerumen or retention
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention ... Treatment #management #opportunistic
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Recommendations for Preventing ... Preventing Development ... and uncontrolled HIV ... measure for the prevention ... Treatment #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... 400 mg) PO or IV ... mucosal #IDSA #Prevention ... Treatment #management #opportunistic